News

Nearly 7 million people in the U.S. are living with Alzheimer’s disease. That number is expected to double by the year 2060.

Cardiovascular Business spoke with Dr. Timothy Bateman about his views on SPECT advances and its longevity in the coming years.

Dr. Timothy Bateman spoke with Cardiovascular Business about his group's findings and what it is like to work with flurpiridaz.

Lynn vividly remembers how she felt when she found out she had stage 2 breast cancer at age 44, shortly after cancer claimed her sister’s life.